Highlight Therapeutics

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Clinical Trial to Evaluate BO-112 in Patients With Basal Cell Carcinoma (BCC)	Neoplasms by Histologic Type, basal cell carcinoma, basal cell neoplasm, carcinoma, epithelial neoplasm, neoplasm	Active, not recruiting	Phase 2	2026-09-17		NCT06422936
Nivolumab and BO-112 Before Surgery for the Treatment of Resectable Soft Tissue Sarcoma	Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, Neoplasms, Fibrous Tissue, Neoplasms, Nerve Tissue, connective tissue neoplasm, dermatofibrosarcoma protuberans, fibrosarcoma, histiocytoma, leiomyosarcoma, malignant giant cell tumor of soft parts, myomatous neoplasm, myxofibrosarcoma, neoplasm, nerve sheath neoplasm, nervous system disorder, neurofibroma, neurofibrosarcoma, neuromuscular disease, peripheral nervous system disorder, peripheral nervous system neoplasm, pleomorphic rhabdomyosarcoma, sarcoma, synovial sarcoma, undifferentiated high grade pleomorphic sarcoma of bone, undifferentiated pleomorphic sarcoma, undifferentiated pleomorphic sarcoma, inflammatory variant	Active, not recruiting	Phase 1	2026-03-10		NCT04420975

Clinical trials